Haem - Lymphoma 1 and 2 Flashcards

(45 cards)

1
Q

Define lymphoma

A

Neoplastic (malignant) proliferation/tumour of lymphoid cells to form discrete tissue masses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In which sites may lymphoma be found

A

Lymph nodes, bone marrow and/or blood (the lymphatic system)
Lymphoid organs; spleen or the gut-associated lymphoid tissue
Skin (often T cell disease; e.g. Mycoses Fungoides)
Rarely “anywhere” (Sanctuary sites: CNS, ocular, testes, breast, etc.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the types of lymphoid malignancies

A

Hodgkin’s
- Classical
- Nodular lymphocyte predominant

Non-Hodgkin’s
- B cell (most common - 80%)
- T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the types of classical Hodgkins lymphoma

A

Nodular sclerosing
Mixed cellular
Lymphocyte depletion
Lymphocyte rich

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the types of B cell non-Hodgkin lymphoma

A

Low grade
MALToma
Small lymphocytic lymphoma (CLL)
Follicular

High grade
Diffuse large B cell lymphoma (DLBCL)
Mantle cell

Aggressive
Burkitt’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the types of T cell non-Hodgkin lymphoma

A

Anaplastic large cell lymphoma
Adult T cell leukaemia lymphoma (ATLL)
Enteropathy-associated T-cell lymphoma (EATL)
Cutaneous (mycoises fungoides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the positives and negatives of DNA instability in the immune system

A

Positive
Allows for recombination → diversity
Rapid proliferation for rapid response to infection
Apoptosis dependency for specificity, elimination of self-reactive clones

Negative
Recombination → unwanted point mutations
Rapid proliferation → replication errors
Apoptosis dependency: apoptosis may be switched off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the stages of immunoglobulin and TCR gene recombination

A
  1. VDJ recombination in the bone marrow involving RAG1 and RAG2
  2. Class switch recombination: somatic hypermutation in the germinal centre - heavy chain of Ig changed and the oncogenes are brought closer to the promoter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the divisions of the lymphoreticular system

A
  1. Generative lymphoreticular (LR) tissue - generation/maturation of lymphoid cells in bone marrow and thymus
  2. Reactive LR - immune reaction in lymph nodes and spleen
  3. Acquired LR tissue - local immune reaction in extra-nodal tissue (skin, stomach, lungs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the histology of a lymph node

A

Germinal centre of B cells and antigen presenting cells
Surrounded by the mantle zone - naive, unstimulated B cells
Surrounded by a paracortical T cell zone
Lymph node sinuses between follicles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What investigations should be done for lymphoma

A

Bloods:
- LDH: raised
- Albumin
- U&Es
- HIV, hep B serology ± HTLV-1 (ensure hep B will not reactivate)

Anatomical stage
- bone marrow biopsy
- CT/PET
- Lumbar puncture if risk of CNS involvement

Cytology (cells aspirated from lump)
Histology (tissue sections)

Cytogenetics
FISH - chromosomal translocations
PCR - chromosomal translocations, gene rearrangement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the lymphoma CD markers for NHL

A

CD19, CD20 = B-cells
CD3, CD5 = T-cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which Ig are associated with B cell lymphomas

A

Follicular NHL: IgH-BCL2
Mantle Cell lymphoma: IgH-Cyclin D1
Burkitt Lymphoma: IgH-MYC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the symptoms of lymphoma

A

Painless progressive lymphadenopathy (neck, axilla groin)
Compression symptoms
- Renal failure
- Obstructive jaundice
- Large blood vessels
- Bowel obstruction
- Trachea
- Oesophageal
Infiltration
- Brain: stroke, lOC, memory problems
- Skin rash: plaques, ulceration, nodules
- Ocular: blindess
- Liver: liver failure
Recurrent infections
B symptoms: fever, night sweats, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What should be looked at for histology of a lymphoma

A
  • Architecture: nodular, diffuse
  • Histology: small round, small cleaved, large cells
    Immunophenotyping:
  • Cell types (CD markers)
  • Cell distribution
  • loss of surface proteins
  • Abnormal expression of proteins
  • Clonality of B cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the features of follicular lymphoma (epidemiology, time course, molecular, histopathology)

A

Middle-aged or elderly
Indolent, relatively incurable
t(14;18) involving bcl-2 gene
Histo: neoplastic follicles, positive CD10 and bcl-2 staining, centroblasts (lymph node biopsy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the features of small lymphocytic lymphoma (association, epidemiology, histopathology)

A

CLL
Associated with Richter transformation (presents with NEW B symptoms)
Middle aged or elderly
Histo: small lymphocytes, arises from naive B cells, CD5 and CD23 positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the features of marginal zone lymphoma/MALToma (cause, timeline, management)

A

Response to chronic antigenic stimulation
Post germinal centre memory B cell
Indolent but could transform
Management: remove the antigenic stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Give examples of MALT and their causes

A

H. pylori → gastric
Sjogren’s → parotid gland
Hashimotos → thyroid MZL
Psittaci infection → lacrimal gland

20
Q

What are the features of diffuse large B cell lymphoma (epidemiology, histopathology, prognosis)

A

Middle aged and elderly
Histo: from germinal centre/post-germinal centre, sheets of large lymphoid cells
p53+: Poor prognosis

21
Q

What are the features of mantle cell lymphoma (epidemiology, histopathology, molecular associations, prognosis)

A

Middle aged males
Histo: seen in the mantle zone, arising from pre-germinal centre cells, expression of CD5 and cyclin D1, clefted nuclei
Molecular: t(11;14), cyclin D1 overexpression
Prognosis: 2-5 years

22
Q

What are the features of Burkitt’s lymphoma (presentation, association, histopathology, molecular associations)

A

Jaw/abdo mass when young
Associated with EBV
Histo: starry-sky appearance, arises from germinal centre cells
Molecular: C-myC translocation (8;14) OR (2;8) OR (8;22)

23
Q

What are the features of anaplastic large cell lymphoma (epidemiology, histopathology, molecular associations, prognostic factors)

A

Younger patients
Histo: large epithelioid lymphocyte, anaplastic
Molecular: t(2;5)
Alk-1 protein expression = better prognosis

24
Q

Describe enteropathy associated T-cell lymphoma (cause and association, histology, presentation, response to treatment, prevention)

A

Caused by chronic antigen stimulation to gluten/gliadin → associated with coeliac disease
Histology: Mature T cells TdT, CD19
Presentation:
- Abdo pain, obstruction, perforation, GI bleeding
- Malabsorption
- Systemic symptoms

Responds poorly to chemotherapy, generally fatal
Can be prevented by strict adherence to a gluten-free diet

25
What are the associations with Adult T cell leukaemia lymphoma (ATLL)
HTLV-1 infection Japanese and Caribbean ethnicity Histo: flower cells
26
What is cutaneous T cell NHL associated with
Mycosis fungoides
27
What is the epidemiology of Hodgkin's lymphoma
1% of all cancer Less common than non-Hodgkin's M > F Bimodal age - 20-29yo (most common), >60yo (smaller peak)
28
What are the symptoms of Hodgkin's lymphoma
Asymmetric painless lymphadenopathy Pain in nodules after alcohol ingestion
29
What are the diagnostic features of hodgkin's lymphoma on investigation
From germinal centre OR post-germinal centre Associated with EBV Histo: sclerosis, Reed-Sternberg cells (binucleate), lymphoma cells, Eosinophils Markers: CD30+, CD15+, CD20 -ve
30
Describe the features of nodular sclerosing HL sub-type (epidemiology, symptoms)
Young women (20-29) Neck nodes and a mediastinal mass → SVC or trachea compression Spreads contiguously
31
What are the features of nodular lymphocyte predominant lymphoma (presentation, association, histopathology, diagnostic markers)
Isolated lymphadenopathy May transform to a high grade B cell NHL Histo: b cell rich nodules, NO eos/macro NEGATIVE for CD30 + CD15 (which is seen in classical Hodgkin) POSITIVE for CD20
32
Describe the staging of lymphoma
Ann Arbor Staging A = B symptoms absent B = B symptoms present E = involvement of single, contiguous, or proximal extranodal site I: One node region involved on 1 side of the diaphragm II: 2+ ipsilateral regions involved on 1 side of the diaphragm III: Bilateral node involvement on both sides of the diaphragm IV: HL: Involvement of extranodal sites beyond those designated by ‘E’ (below) NHL: Disseminated/multifocal involvement of ≥1 extralymphatic site OR isolated extralymphatic organ involvement with distant node involvement
33
Describe the treatment of Hodgkin's lymphoma
Chemotherapy: ABVD (2-6 cycles, 4-weekly intervals) - adriamycin, bleomycin, vinblastine, DTIC (Dacarbazine) ± radiotherapy Second line: salvage chemotherapy (high dose chemo + HSCT) Third line: anti-CD30 (Brentuximab Vedotin)+ anti-PD1(nivolumab)
34
What is the management for NHL
Chemotherapy: R-CHOP (6-8 cycles) - rituximab, cylophosphamide, adriamycin, vincristine, prednisolone Second line: autologous HSCT
35
What is the prognosis for NHL
Burkitt's lymphoma – fastest growing human cancer Follicular lymphoma (an indolent disease) – possible 25 year survival HOWEVER, chance of being cured increases with more aggressive neoplasms
36
What are the prognostic markers for NHL
LDH (marker of cell turnover) Performance status HIV serology Hep B serology (treatment for lymphoma may cause a dormant hep B to reactivated → fulminant liver failure)
37
What is a common complication of Chemotherapy + radiotherapy for Hodgkin's lymphoma
Risk of damage to normal tissues (collateral damage) Associated with increased risk of breast/lung/skin cancer, leukaemia/myelodysplasia
38
What is the prognosis for Hodgkin's lymphoma
Elderly patients do worse than the worst-prognosis HL (lymphocyte-depleted type) It is a highly curable disease, but the prognosis depends on stage Over 80% in stage I or II disease are cured 50% of stage IV are cured 10% die from relapse within 10 years and 10% die from complications after 10 years More likely to die of secondary malignancy of CV complications after 5 years
39
What phenotype is indicative of CLL
Normal T cells are CD5 positive, and CD 19 and 20 negative. While normal B cells are the other way around. CLL B cells have an unusual phenotype (Monoclonal lymphocytosis with abnormal expression of CD5 = highly suggestive of CLL)
40
What is the phenotype of T cells
CD3 positive CD4 or CD8 positive (Th-cell, CTL cell) CD19 NEGATIVE CD5 POSITIVE
41
What is the prognosis for CLL
In a disorder of elderly - 1/3 never progress - 1/3 Progress, respond to CLL Rx (death from unrelated disorder) - 1/3 Progress, require multiple lines of Rx, refractory disease, death from CLL
42
How is CLL staged
Rai and Binet staging A: <3 lymphoid areas B: >3 lymphoid areas C Hb <100, Platelets <100
43
What are the complications of CLL
Non-functioning B cell production → hypogammaglobulinaemia → increased infection risk e.g. pneumonia, sinusitis Metastasis to lymphoid organs e.g. lymph nodes, spleen Bone marrow failure (anaemia, neutropenia thrombocytopenia) Richter transformation → high grade lymphoma Regulation of the surviving normal B cell population → autoimmune disease e.g. autoimmune haemolytic anaemia
44
What are the prognostic lab factors for CLL
Cytogenetics (FISH panel) Immunoglobulin gene (IgHV) mutation status - IgH mutated - IgH unmutated (Bad) 17p deletion p53 muted
45
What are the poor prognostic features of CLL
Deletion of 13q (~133 months survival) Trisomy 12 (~114) Deletion of 11q (ATM) (~79) Deletion of 17p (TP53) - loss of p53 tumour